Artisan Partners’s Edgewise Therapeutics EWTX Stock Holding History

Artisan Partners’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.4M	Sell	574,925 -84,142	-13%	-$2.9M	0.04%	241
2026 Q1	$20.8M	Sell	659,067 -45,010	-6%	-$1.3M	0.03%	281
2025 Q4	$17.5M	Sell	704,077 -14,098	-2%	-$283K	0.03%	301
2025 Q3	$11.6M	Sell	718,175 -660,893	-48%	-$9.37M	0.02%	304
2025 Q2	$18.1M	Buy	1,379,068 +461,846	+50%	+$6.66M	0.03%	295
2025 Q1	$20.2M	Sell	917,222 -154,374	-14%	-$4.05M	0.03%	282
2024 Q4	$28.6M	Buy	1,071,596 +70,964	+7%	+$2.26M	0.04%	284
2024 Q3	$26.7M	Buy	+1,000,632	New	+$19.9M	0.04%	273

Other funds holding EWTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Artisan Partners's EWTX Position: Q2 2026 in Review

Artisan Partners reduced its Edgewise Therapeutics (EWTX) stake by 13% in Q2 2026, selling an estimated $2.9M and leaving 574,925 shares worth $23.4M. The position accounts for 0.04% of the portfolio, ranked #241.

Artisan Partners first reported a position in EWTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $28.6M in Q4 2024. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

Artisan Partners held 574,925 shares of Edgewise Therapeutics worth $23.4M as of Q2 2026.
Artisan Partners sold 84,142 Edgewise Therapeutics shares in Q2 2026, an estimated $2.9M.
Edgewise Therapeutics made up 0.04% of Artisan Partners's portfolio in Q2 2026, its #241 holding.
Artisan Partners first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 8 quarters since.
Artisan Partners's Edgewise Therapeutics position peaked at $28.6M in Q4 2024.
226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.